Prostate-cancer screening [4]

New England Journal of Medicine

Volumn 361, Issue 2, 2009, Pages 203-

  Ojha, Rohit P ^a   Thertulien, Raymond ^b   Fischbach, Lori A ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b ClinWorks Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; DEATH CERTIFICATE; DIGITAL RECTAL EXAMINATION; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; BLOOD; EPIDEMIOLOGY; MALE; MASS SCREENING; MORTALITY; NOTE; PROSTATE TUMOR; UNITED STATES;

BIAS (EPIDEMIOLOGY); CAUSE OF DEATH; HUMANS; MALE; MASS SCREENING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 67650494300     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer - part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999;91:1025-32.
2. Incidence-based mortality. Bethesda, MD: National Cancer Institute, Statistical Research and Applications, 2006. (Accessed June 18, 2009, at http://srab.cancer.gov/statistics/ibm/.)